Article

jdsupra.com on 2020-06-10 20:22

Medicaid Drug Rebate Program: CMS addresses authorized generics, drug category narrow exception in manufacturer releases 112 and 113

The Centers for Medicare & Medicaid Services (CMS) recently issued two manufacturer releases. The first provides further information regarding the ...

Related news

CMS Finalizes Changes to Medicaid Prescription Drug Rebate Program jdsupra.com
Americas , United States
Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023 jdsupra.com
Reg , Best Price
Fair and Accurate Medicaid Pricing Act Becomes Law: Officially Closes AMP “Loophole” Related to Authorized Generics jdsupra.com
California , United States , Switzerland
CMS Finalizes Helpful Change to Stark Law Signature Exception jdsupra.com
California , United States , Switzerland
How Drug Companies Use Authorized Generics To Keep Drug Prices High Forbes
Save money with authorized generics state-journal.com
India
HHS Proposes to Remove Drug Rebate Protections jdsupra.com
California , United States , Switzerland
CMS Issues Guidance on Medicare Prescription Drug Inflation Rebate Program jdsupra.com
Maryland
CMS Proposes Changes to Lower Drug Prices jdsupra.com
California , United States , Switzerland
Authorized generics may have better quality abqjournal.com
India
Billionaire Mark Cuban Wants To Lower Drug Prices With Generics Startup Forbes
Trenton , Brussels , Oregon , Alabama , Dallas
CMS proposes new Stark Law exception for limited remuneration to a physician jdsupra.com
California , United States , Switzerland
CMS Proposes New Limitations to the Isolated Transactions Exception to the Stark Law jdsupra.com
California , United States , Switzerland
CMS Issues Revised Medicare Part B and Part D Inflation Rebate Guidance jdsupra.com
United States
CMS Delays Expanding Medicaid Rebate Program, Price Reporting Requirements to Territories Until 2020 jdsupra.com
Virgin Islands , Puerto Rico , Guam , Northern Mariana Islands , American Samoa
CMS issues Medicare Part B and Part D inflation rebate guidance jdsupra.com
United States
The Medicaid Drug Rebate Program and Value-Based Purchasing jdsupra.com
Best Price
Administration Proposes Changes to the Drug Rebate Program jdsupra.com
California , United States , Switzerland
CMS Proposes to Rescind Most Favored Nation Drug Pricing Rule jdsupra.com
Reg , United States
CMS Specifies Info Needed for Small Biotech Exception to Medicare Drug Price Negotiation jdsupra.com